Cargando…
Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis
BACKGROUND: Epigenetic studies demonstrate that an association may exist between methylation of the retinoic acid receptor beta2 (RARβ2) gene promoter and breast cancer onset risk, tumor stage, and histological grade, however the results of these studies are not consistent. Hence, we performed this...
Autores principales: | Fang, Cheng, Jian, Zhi-Yuan, Shen, Xian-Feng, Wei, Xue-Mei, Yu, Guo-Zheng, Zeng, Xian-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599915/ https://www.ncbi.nlm.nih.gov/pubmed/26451736 http://dx.doi.org/10.1371/journal.pone.0140329 |
Ejemplares similares
-
Reduced Retinoic Acid Receptor Beta (Rarβ) Affects Pancreatic β-Cell Physiology
por: Khalique, Anila, et al.
Publicado: (2022) -
Association analysis of retinoic acid receptor beta (RARβ) gene with high myopia in Chinese subjects
por: Ding, Yang, et al.
Publicado: (2010) -
The Association of Retinoic Acid Receptor Beta2(RARβ2) Methylation Status and Prostate Cancer Risk: A Systematic Review and Meta-Analysis
por: Gao, Tianyi, et al.
Publicado: (2013) -
Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis
por: Wen, Guohong, et al.
Publicado: (2018) -
Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis
por: Qi, Ming, et al.
Publicado: (2018)